Literature DB >> 29147836

Effects of saffron and its constituents, crocin-1, crocin-2, and crocetin on α-synuclein fibrils.

Eiji Inoue1, Yasuharu Shimizu2, Ryo Masui2, Tomomi Hayakawa2, Tomoe Tsubonoya2, Satoko Hori2, Keiichi Sudoh2.   

Abstract

Saffron, the stigma of Crocus sativus Linné (Iridaceae family), has been known to inhibit aggregation of β-amyloid, a nerve tissue protein. α-Synuclein (αS) is a 140-amino acid protein found abundantly in various regions of the brain. Its abnormal aggregation and accumulation in nerve tissue are said to cause neurodegenerative diseases such as Parkinson's disease, Lewy body dementia, and multiple-system atrophy. This study (part of this study was presented at the 137th Annual Meeting of the Pharmaceutical Society of Japan) examined the effects of saffron, its constituents (crocin-1, crocin-2, crocetin, and safranal), and crocetin structural analogs (hexadecanedioic acid, norbixin, and trans, trans-muconic acid) on αS aggregation, and αS fibril dissociation. Saffron dose-dependently inhibited αS aggregation and dissociated αS fibrils by thioflavin T fluorescence assay. These effects were observed by transmission electron microscopy, which showed reduced and shortened αS fibrils. Crocin-1, crocin-2, and crocetin showed anti-aggregation and fibril dissociation effects, with crocetin being the most potent. The effects of norbixin were weaker than those of crocetin, and the other crocetin structural analogs showed no effects. These results show that saffron and its constituents (crocin-1, crocin-2, and crocetin) can be effective in preventing and treating diseases caused by abnormal αS aggregation.

Entities:  

Keywords:  Crocetin; Crocin-1; Crocin-2; Saffron; α-Synuclein

Mesh:

Substances:

Year:  2017        PMID: 29147836     DOI: 10.1007/s11418-017-1150-1

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  16 in total

Review 1.  Alpha-synuclein and neurodegenerative diseases.

Authors:  M Goedert
Journal:  Nat Rev Neurosci       Date:  2001-07       Impact factor: 34.870

2.  Crocetin inhibits beta-amyloid fibrillization and stabilizes beta-amyloid oligomers.

Authors:  Joon Ho Ahn; Yang Hu; Michael Hernandez; Jin Ryoun Kim
Journal:  Biochem Biophys Res Commun       Date:  2011-09-14       Impact factor: 3.575

3.  Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils.

Authors:  Mustafa T Ardah; Katerina E Paleologou; Guohua Lv; Sindhu A Menon; Salema B Abul Khair; Jia-Hong Lu; Bared Safieh-Garabedian; Abdulmonem A Al-Hayani; David Eliezer; Min Li; Omar M A El-Agnaf
Journal:  Neurobiol Dis       Date:  2014-11-15       Impact factor: 5.996

4.  Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry.

Authors:  R L Hamilton
Journal:  Brain Pathol       Date:  2000-07       Impact factor: 6.508

5.  Vitamin A potently destabilizes preformed alpha-synuclein fibrils in vitro: implications for Lewy body diseases.

Authors:  Kenjiro Ono; Masahito Yamada
Journal:  Neurobiol Dis       Date:  2006-12-12       Impact factor: 5.996

6.  Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents.

Authors:  Magdalini A Papandreou; Charalambos D Kanakis; Moschos G Polissiou; Spyros Efthimiopoulos; Paul Cordopatis; Marigoula Margarity; Fotini N Lamari
Journal:  J Agric Food Chem       Date:  2006-11-15       Impact factor: 5.279

7.  Inhibition effects of tanshinone on the aggregation of α-synuclein.

Authors:  Kaige Ji; Yudan Zhao; Tianhong Yu; Zhuoyi Wang; Hao Gong; Xin Yang; Yang Liu; Kun Huang
Journal:  Food Funct       Date:  2016-01       Impact factor: 5.396

8.  Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity.

Authors:  Mustafa T Ardah; Katerina E Paleologou; Guohua Lv; Salema B Abul Khair; Abdulla S Kazim; Saeed T Minhas; Taleb H Al-Tel; Abdulmonem A Al-Hayani; Mohammed E Haque; David Eliezer; Omar M A El-Agnaf
Journal:  Front Aging Neurosci       Date:  2014-08-05       Impact factor: 5.750

9.  Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.

Authors:  Igor F Tsigelny; Leslie Crews; Paula Desplats; Gideon M Shaked; Yuriy Sharikov; Hideya Mizuno; Brian Spencer; Edward Rockenstein; Margarita Trejo; Oleksandr Platoshyn; Jason X-J Yuan; Eliezer Masliah
Journal:  PLoS One       Date:  2008-09-04       Impact factor: 3.240

10.  Simultaneous quantification of crocetin esters and picrocrocin changes in Chinese saffron by high-performance liquid chromatography-diode array detector during 15 years of storage.

Authors:  Yingpeng Tong; Yongqiu Yan; Xingyi Zhu; Ruoxi Liu; Feng Gong; Ling Zhang; Ping Wang
Journal:  Pharmacogn Mag       Date:  2015 Jul-Sep       Impact factor: 1.085

View more
  3 in total

Review 1.  Amelioration of Mitochondrial Quality Control and Proteostasis by Natural Compounds in Parkinson's Disease Models.

Authors:  Bongki Cho; Taeyun Kim; Yu-Jin Huh; Jaemin Lee; Yun-Il Lee
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

Review 2.  Crocetin: A Systematic Review.

Authors:  Zi-Liang Guo; Mao-Xing Li; Xiao-Lin Li; Peng Wang; Wei-Gang Wang; Wei-Ze Du; Zhi-Qiang Yang; Sheng-Fu Chen; Di Wu; Xiu-Yu Tian
Journal:  Front Pharmacol       Date:  2022-01-14       Impact factor: 5.810

3.  Gut Bacteria Regulate the Pathogenesis of Huntington's Disease in Drosophila Model.

Authors:  Anjalika Chongtham; Jung Hyun Yoo; Theodore M Chin; Ngozi D Akingbesote; Ainul Huda; J Lawrence Marsh; Ali Khoshnan
Journal:  Front Neurosci       Date:  2022-06-02       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.